News
There are currently no news stories available for this symbol.
RELATED RESOURCES |
Snapshot: XDNAKELLY CRISPR & GENE EDITING TECHNOLOGY ETF9.60 as of 10:28:45am ET 05/19/2022
Quotes delayed at least 15 min.
Log in for real time quote.
|
ETP TypeETF Asset ClassEquity Net Assets
|
Price / Earnings (Trailing Twelve Months) | 18.80 |
---|---|
Price / Book | 2.65 |
Price / Sales | 7.10 |
Price / Cash Flow | 14.17 |
30-day SEC Yield AS OF -- | -- |
Distribution Yield (TTM) AS OF 04/29/2022 |
-- |
XDNA KELLY CRISPR & GENE EDITING TECHNOLOGY ETF |
Asset Class Median | |
---|---|---|
Volume (10-Day Avg) AS OF 05/18/2022 |
3.2K | 22.3M |
1 Month Market Total Return AS OF 05/18/2022 |
-15.79 | -5.79% |
1 Year Market Total Return AS OF 04/30/2022 |
-- | -4.84% |
3 Year Annualized Market Total Return AS OF 04/30/2022 |
-- | +7.80% |
Beta (1 Year Month-End) AS OF 05/18/2022 |
-- | 0.85 |
Annual Turnover Ratio AS OF -- |
-- | 30.00% |
Net Expense Ratio AS OF 12/31/2021 |
0.78% | 0.56% |
NAV Return | Market Return | |
---|---|---|
1 Year | -- | -- |
3 Year | -- | -- |
5 Year | -- | -- |
10 Year | -- | -- |
Life | -15.45 | -14.56 |
The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.
More about Performance & RiskCRISPR Therapeutics AG | 10.82% | |
---|---|---|
EDIT | Editas Medicine Inc | 10.35% |
NTLA | Intellia Therapeutics Inc | 6.65% |
BEAM | Beam Therapeutics Inc | 6.42% |
ALLO | Allogene Therapeutics Inc | 6.11% |
ABBV | AbbVie Inc | 6.03% |
TMO | Thermo Fisher Scientific Inc | 6.01% |
A | Agilent Technologies Inc | 5.52% |
ILMN | Illumina Inc | 5.49% |
CRBU | Caribou Biosciences Inc Ordinary Shares | 4.96% |
Value | Blend | Growth | |
---|---|---|---|
Large | |||
Mid | ![]() |
||
Small |
Commentary